Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Ancell
anti-CD273 [B7-DC/PD-L2] (human), mAb (ANC8D12) (preservative free)
306
CHF
CHF 306.00
In stock
ANC-273-820100 µgCHF 306.00
Product Details | |
---|---|
Synonyms | Programmed Death Ligand 2 |
Product Type | Monoclonal Antibody |
Properties | |
Clone | ANC8D12 |
Isotype | Mouse IgG2aκ |
Immunogen/Antigen | Recombinant human CD273. |
Label/Conjugates | Preservative Free |
Application |
FACS |
Crossreactivity | Human |
Purity | ≥95% (SDS-PAGE) |
Formulation | 50mM Sodium Phosphate pH 7.5, 100mM Potassium Chloride, 150mM NaCl. |
Isotype Negative Control | |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Ancell Corporation. |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice |
Avoid freeze/thaw cycles. Keep sterile. |
Use/Stability | Stable for at least 1 year after receipt when stored at +4°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
CD273 (B7-DC; PD-L2) is a type I surface molecule with homology to CD80, CD86, CD274. It is expressed primarily by dendritic cells and provides a stimulatory signal to CD279 (PD-1; Programmed Cell Death 1) which has an important immunoregulatory role by downregulating the T cell response. CD273 binds to CD279 (PD-1) with a 2-6 fold higher affinity than CD274 and is an important component of immune regulation.